SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2024 quarter is pegged at Rs. 331.88 millions, about 16.69% up against Rs. 284.42 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2024 of Rs. 9.48 millions grew from Rs.-29.43 millions Operating profit Margin for the quarter ended December 2024 improved to 32.51% as compared to -10.96% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 331.88 284.42 16.69 1067.97 1110.67 -3.84 1524.66 1153.50 32.18
Other Income 1.90 9.79 -80.59 17.17 30.07 -42.90 35.22 32.73 7.61
PBIDT 32.51 -10.96 -396.62 97.82 112.30 -12.89 146.34 189.90 -22.94
Interest 6.35 5.76 10.24 19.09 16.15 18.20 22.90 20.38 12.37
PBDT 26.04 -16.72 -255.74 75.16 96.15 -21.83 123.44 169.52 -27.18
Depreciation 16.56 12.71 30.29 46.75 37.24 25.54 49.95 53.34 -6.36
PBT 9.48 -29.43 -132.21 28.41 58.91 -51.77 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 9.48 -29.43 -132.21 28.41 58.91 -51.77 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 9.80 -3.85 -354.20 9.16 10.11 -9.41 9.60 16.46 -41.70

Bafna Pharma Share Price

145.00 12.40 (9.35%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×